Joy Sturm, partner at Hogan Lovells, joins Off the Shelf for a briefing on the proposed BIOSECURE Act that would reshape biotechnology supply chains serving the federal government. The proposed legislation would prohibit the federal government from contracting with certain Chinese “companies of concern.”  The prohibition would cover contracts, grants, and subcontractors. Sturm provides context on the goals for the legislation and outlines the key provisions and how they would impact federal contracts, agencies, and contractors. She addresses the proposed legislation’s key definitions, contracting restrictions, scope of coverage, and implementation timelines. Importantly, Sturm also addresses how companies should prepare for the BIOSCURE Act requirements. The discussion concludes with thoughts on the prospects for the proposed BIOSECURE Act over the reminder of the Congressional year.